<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170506033834N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-20</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of in-home and phone supportive counseling on postpartum depression and anxiety: a randomized controlled clinical trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of in-home and phone supportive counseling on postpartum depression and anxiety: a randomized controlled clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>93</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71775</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The participants were divided into two intervention groups (recipients of supportive counseling at home and supportive counseling over the phone) and a control group (recipients of routine care after delivery) will be allocated. For concealment, the type of allocation will be written on paper and placed in numbered opaque envelopes (Allocation Concealment). The envelopes will be opened in order and by a person not involved in sampling, Blinding description: In this study, according to the nature of the study, it will not be possible to blind the participants and the researcher, and only the evaluator of the results will be a blind person.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Postpartum.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In one of the intervention groups, supportive counseling will be done at home during three sessions on days 5-3 7-9 and 20-25 after delivery for 30-45 minutes .The content of the counseling sessions according to the support counseling protocol will be as follows: The first session (3-5 days after delivery): includes encouraging to talk about the questions and problems that the person has in the process of self-care and caring for the baby and about breastfeeding. Also, criteria of sufficient amount of breast milk, the reasons of infants' crying and refusing to take the breast, nutrition of mothers during breastfeeding, methods to increase breast milk, breast problems, constipation, back pain, care of episiotomy sutures and pain management, and care of the baby's umbilical cord will be explained. The second session (7-9 days after delivery): in this session, in relation to how to store milk and continue breastfeeding, fatigue and the matching of sleeping and waking time with the baby, how the mother interacts with the child, perceived supports, self-care and coping with the responsibilities will be explained. The purpose of this meeting is to recount the person's emotional-emotional reactions to the new situation, and the counselor is looking for performance disturbances, signs such as stress and wrong adaption to explain how to deal with it (teaching relaxation techniques, seeking and attracting social support, improving communication skills with others and especially with husbands). The third session (20-25 days after delivery): in this session, we will talk about the time to resume sexual relations, and contraception methods in breastfeeding mothers and the continuation of breastfeeding. Relaxation techniques will be reviewed and summarized the session details. Intervention 2: Intervention group: In the other intervention group, phone support counseling will be done in three sessions on days 9-9, 7-3 and 20-25 after delivery for 30-45 minutes. The content of this type of counseling will be the same as home support counseling. If the client needs, one more meeting will be held in each of the groups with prior coordination of the clients. The counseling time will be determined according to the previous agreement with the participants. Intervention 3: Control group: In this study, the control group will receive only the usual care after delivery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No more data</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>bita eskandari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, South Shariati, Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5313644351</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>bitaeskandari7250@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Roghaiyeh Nourizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, South Shariati St., Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>nourizadehr@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Primiparous women by vaginal method
Having a desire to breastfeed
Age 18-45
Living in Tabriz
Single birth
Mothers with term babies weighing 2500 to 4000 grams</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Mothers with hospitalized babies.
Existence of systemic and chronic diseases or aggravating disorders during pregnancy and childbirth, including gestational or overt diabetes, blood pressure disorders, heart disease, and the inability of the mother to care for the baby.
Breast anomaly or history of breast surgery
The existence of unfortunate events in the last three months, including the death of loved ones, divorce, etc.
Obtaining a depression score of 13 or more based on the Edinburgh postpartum depression scale
Depressive disorders before pregnancy and delivery according to mother's statement
Cases of malformation and infant death
Excessive bleeding during childbirth
Having breast-feeding contraindications (women undergoing chemotherapy, women with HIV infection, women with untreated active tuberculosis, and the use of radioactive, antimetabolite and illegal drugs during breastfeeding such as methotrexate, mercaptopurine, hydroxyurea, tamoxifen, bromocriptine, Lithium, phenin-dione, phen-cyclidine, cyclophosphamide and doxorubicin, drugs and...</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Encounter </hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Z39</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In one of the intervention groups, supportive counseling will be done at home during three sessions on days 5-3 7-9 and 20-25 after delivery for 30-45 minutes .The content of the counseling sessions according to the support counseling protocol will be as follows: The first session (3-5 days after delivery): includes encouraging to talk about the questions and problems that the person has in the process of self-care and caring for the baby and about breastfeeding. Also, criteria of sufficient amount of breast milk, the reasons of infants' crying and refusing to take the breast, nutrition of mothers during breastfeeding, methods to increase breast milk, breast problems, constipation, back pain, care of episiotomy sutures and pain management, and care of the baby's umbilical cord will be explained. The second session (7-9 days after delivery): in this session, in relation to how to store milk and continue breastfeeding, fatigue and the matching of sleeping and waking time with the baby, how the mother interacts with the child, perceived supports, self-care and coping with the responsibilities will be explained. The purpose of this meeting is to recount the person's emotional-emotional reactions to the new situation, and the counselor is looking for performance disturbances, signs such as stress and wrong adaption to explain how to deal with it (teaching relaxation techniques, seeking and attracting social support, improving communication skills with others and especially with husbands). The third session (20-25 days after delivery): in this session, we will talk about the time to resume sexual relations, and contraception methods in breastfeeding mothers and the continuation of breastfeeding. Relaxation techniques will be reviewed and summarized the session details.</i_keyword>
      <i_keyword>Intervention group: In the other intervention group, phone support counseling will be done in three sessions on days 9-9, 7-3 and 20-25 after delivery for 30-45 minutes. The content of this type of counseling will be the same as home support counseling. If the client needs, one more meeting will be held in each of the groups with prior coordination of the clients. The counseling time will be determined according to the previous agreement with the participants.</i_keyword>
      <i_keyword>Control group: In this study, the control group will receive only the usual care after delivery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Postpartum Depression. Timepoint: 10-15 days and 42-60 days after delivery by controlling the effect of baseline score. Method of measurement: Edinburgs Postpartum Depression Scale.</prim_outcome>
      <prim_outcome>Specific postpartum anxiety. Timepoint: 10-15 days and 42-60 days after delivery by controlling the effect of baseline score. Method of measurement: PSAS-RSF(Postpartum Specific Anxiety Scale Research short-form).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life of mothers. Timepoint: 10-15 days after delivery. Method of measurement: MAPP-QOL(Maternal Postpartum Quality).</sec_outcome>
      <sec_outcome>Frequency of exclusive breastfeeding. Timepoint: 42-60 days after birth. Method of measurement: A checklist designed to record breastfeeding status.</sec_outcome>
      <sec_outcome>Comparison of infant weight. Timepoint: One month after giving birth. Method of measurement: Baby weight card.</sec_outcome>
      <sec_outcome>Comparison of the frequency of newborn visits by doctors. Timepoint: 42-60 days after birth. Method of measurement: Checklist designed to record the number of baby visits by the doctor.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-12</approval_date>
        <contact_name>Ethics Commite of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Golgasht St., Tabriz University of Medical Sciences, Faculty of Dentistry Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
